ENTITY
WuXi XDC Cayman (2268 HK)
WuXi XDC Cayman (2268 HK)
50
Analysis
Health Care • China
WuXi XDC Cayman Inc. operates as a leading contract testing, development and manufacturing organization focused on the global antibody drug conjugates and broader bioconjugate market. The Company provides bioconjugation discovery, analytical development, intermediate and conjugation manufacturing, and other services. WuXi XDC Cayman provides its services worldwide.
more
x